Blinatumomab shows tolerable safety profile and high response rate in paediatric patients with r/r ALL

Tolerable safety profile and high response rate to blinatumomab in paediatric patients with r/r ALL
Tolerable safety profile and high response rate to blinatumomab in paediatric patients with r/r ALL
Tjenesten du prøver å få tilgang til er bare tilgjengelig for registrerte brukere. For å fortsette vennligst logg inn eller registrer deg for en gratis konto på Univadis